Strongly Overvalued
Stocks significantly overpriced based on fundamental analysis, indicating elevated valuation risk.
Valuation
Price
Abivax SA
ABVX
11
$9.94B
-
$119.53
0.49%
AGIG
Abundia Global Impact Group, Inc
AGIG
16
$51.21M
-
$1.13
-4.31%
ABVC Biopharma Inc
ABVC
16
$28.25M
-
$0.99
-8.49%
AC Immune SA
ACIU
11
$349.56M
-
$2.76
-0.72%
Actuate Therapeutics Inc
ACTU
16
$32.90M
-
$1.26
-6.57%
Ads-Tec Energy PLC
ADSE
16
$1.01B
-
$11.60
0.69%
Adverum Biotechnologies Inc
ADVM
11
$96.26M
-
$4.59
5.50%
Aemetis Inc
AMTX
16
$127.02M
-
$1.84
3.98%
AEON Biopharma Inc
AEON
11
$11.72M
-
$0.23
2.13%
AIIR
Air Global PLC
AIIR
11
$1.15B
-
$7.28
8.38%
Air Products and Chemicals Inc
APD
16
$66.30B
0.61%
$295.27
-0.82%
Alaunos Therapeutics Inc
TCRT
11
$3.99M
-
$1.56
-0.64%
Albertsons Companies Inc
ACI
16
$5.89B
-
$11.85
-2.39%
Alector Inc
ALEC
16
$275.79M
-
$2.25
-8.50%
Allarity Therapeutics Inc
ALLR
16
$19.89M
-
$1.26
0.79%
Alpha Modus Holdings Inc
AMOD
11
$10.27M
-
$1.95
-5.34%
American Resources Corp
AREC
11
$262.08M
-
$2.33
-5.71%
AnaptysBio Inc
ANAB
11
$1.68B
-
$55.70
-1.61%
Apollomics Inc
APLM
11
$53.80M
-
$24.88
2.08%
Applied Therapeutics Inc
APLT
5
$14.86M
-
$0.10
6.80%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply